Danaher announced on Monday that it agreed to acquire biotech company Abcam in a deal valued at $5.7 billion.
August 28, 2023 - 15:58
By Pharos Investment Advisors Comments are Off
Danaher announced on Monday that it agreed to acquire biotech company Abcam in a deal valued at $5.7 billion.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014

Copyright 2023©. All Rights Reserved